HSBC Holdings plc (HBC1)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 16.20 |
|---|---|
| 52-week range | 11.38 – 18.84 |
| Return, 1 month / 3 months | −8.4% / −9.1% |
| Return, 1 year / 3 years | +48.0% / +175.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 26.3% |
| Worst drawdown (1 year) | -14.6% |
| Average daily value traded | 5.33M EUR |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
HSBC Holdings plc is a banking and financial services group based in London. It provides personal banking, mortgages, credit cards, savings and wealth management to retail customers, and offers commercial banking, lending, trade finance and treasury services to businesses. Its global banking and markets arm serves large companies and institutional clients with financing, payments and investment services. The group operates across Asia, Europe, the Middle East and the Americas, with a particularly strong presence in Hong Kong and the United Kingdom.
On this site HSBC Holdings plc appears as a stock on the XETRA Stock Exchange (Germany), code HBC1, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
HSBC Holdings plc (HBC1) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 16.20 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 61 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 48.0% and over the last three months it fell 9.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.2% | ||
| From 52-week high | -13.3% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.1% | ||
| 6-month return | 5.7% | ||
| 12-month return, skipping the last month | 61.5% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.6% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 5.33M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | −8.4% |
| 3 months | −9.1% |
| 6 months | +5.7% |
| 1 year | +48.0% |
| 3 years | +175.7% |
| 5 years | +320.1% |
Signals
| 50-day / 200-day average | 17.49 / 16.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0890 |
| 14 May 2026 | GBP 0.0890 |
| 12 Mar 2026 | GBP 0.4003 |
| 6 Nov 2025 | GBP 0.0890 |
| 14 Aug 2025 | GBP 0.0890 |
| 8 May 2025 | GBP 0.0890 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.